NYSEARCA:XPH SPDR S&P Pharmaceuticals ETF (XPH) Price, Holdings, & News $43.27 +0.52 (+1.22%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$42.97▼$43.4550-Day Range$39.24▼$42.7552-Week Range$34.67▼$45.62Volume59,962 shsAverage Volume39,627 shsMarket Capitalization$209.86 millionAssets Under Management$202.89 millionDividend Yield1.55%Net Expense Ratio0.35% Stock AnalysisStock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsStock AnalysisChartDividendHeadlinesHoldingsOwnershipRatings Get SPDR S&P Pharmaceuticals ETF alerts: Email Address About SPDR S&P Pharmaceuticals ETFSPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Fund invests substantially all, but at least 80%, of its total assets in the securities comprising the Index. In addition, the Fund may invest in equity securities that are not included in the Index, cash and cash equivalents or money market instruments, such as repurchase agreements and money market funds. The Pharmaceuticals Index is a modified equal weight index. SSgA Funds Management, Inc. is the Fund's investment advisor.Read More XPH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart XPH ETF News HeadlinesJuly 26 at 7:00 AM | marketbeat.comAstraZeneca Shares Fall Despite EPS Beat and Raised GuidanceAstraZeneca beat earnings-per-share (EPS) estimates and raised guidance, but shares still fell. Investors should watch for developments around the drug Enhertu.July 17, 2024 | marketbeat.comPharmaceutical Stocks - Best Pharmaceutical Stocks to Buy (XPH)Along with biotechnology and biotech companies, the pharma industry is a major part of the overall healthcare market. Pharmaceutical companies include some of the biggest stock gainers and some of the best growth stocks on the market. The pharmaceutical market has many amazing stocks to watch. The pharma industry may also be a good investment for those looking for dividend stocks since so many of the largest pharmaceutical companies pay a dividend to its shareholders. Though the industry has plenty of potential for growth, investors should also be aware that pharma stocks—especially smaller startups—can be risky. Investors buying pharma stocks should make sure to do their research and only invest in pharma stocks as part of a diversified portfolio.July 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.March 30, 2024 | finance.yahoo.comSPDR S&P Pharmaceuticals ETF (XPH)March 28, 2024 | seekingalpha.comXPH: A More Balanced Way To Get Exposure To PharmaceuticalsFebruary 16, 2024 | wsj.comSPDR S&P Pharmaceuticals ETFFebruary 5, 2024 | usatoday.comS&P 500 (SPX) today: Catalent Inc is a top mover, up 10%December 23, 2023 | benzinga.comSPDR S&P Pharmaceuticals ETF (ARCA:XPH), Quotes and News SummaryJuly 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.December 18, 2023 | msn.comSPDR S&P Pharmaceuticals ETF declares quarterly distribution of $0.1744See More Headlines Receive XPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for SPDR S&P Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerSSgA Fund NameSPDR S&P Pharmaceuticals ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:XPH Inception Date6/19/2006 Fund ManagerMichael Feehily, Karl Schneider, Keith Richardson Webwww.spdrs.com Phone+1-617-6644738Fund Focus Asset ClassEquity BenchmarkS&P Pharmaceuticals Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings44 Fund Statistics Assets Under Management$202.89 million Average Daily Volume$51,714.00 Discount/Premium0.04% Administrator, Advisor and Custodian AdministratorSSgA Funds Management, Inc. AdvisorSSgA Funds Management, Inc. CustodianState Street Bank and Trust Company DistributorState Street Global Advisors Funds Distributors, LLC Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerCitadel Options OptionableOptionable Options Volume39 Put Options1 Call Options39 Short Interest378,200 shs Miscellaneous Outstanding Shares4,850,000Beta0.87 Creation Unit50,000 Creation Fee$250.00 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Ad Unstoppable Prosperity“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. SPDR S&P Pharmaceuticals ETF ExpensesTypeXPHHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.35%0.56%0.54%0.51%0.51%Other Expenses0.00%0.33%0.50%0.59%0.54%Total Expense0.35%0.70%0.70%0.74%0.71%Fee Waiver0.00%-0.45%-0.54%-0.69%-0.59%Net Expense0.35%0.61%0.60%0.58%0.58% SPDR S&P Pharmaceuticals ETF (XPH) Holdings & ExposureTop 10 XPH HoldingsIntra-Cellular Therapies(NASDAQ:ITCI)Holding Weight: 4.24%Axsome Therapeutics(NASDAQ:AXSM)Holding Weight: 4.22%Viatris(NASDAQ:VTRS)Holding Weight: 4.09%Eli Lilly and Company(NYSE:LLY)Holding Weight: 3.92%Pfizer(NYSE:PFE)Holding Weight: 3.92%Zoetis(NYSE:ZTS)Holding Weight: 3.92%Arvinas(NASDAQ:ARVN)Holding Weight: 3.88%Catalent(NYSE:CTLT)Holding Weight: 3.81%Johnson & Johnson(NYSE:JNJ)Holding Weight: 3.79%Royalty Pharma(NASDAQ:RPRX)Holding Weight: 3.76%XPH Sector ExposureXPH Industry ExposureFull Holdings Details Key ExecutivesJames E. Ross (Age 52)President, Trustee Peter A. Ambrosini (Age 69)Chief Compliance Officer Michael P. Riley (Age 44)Vice President Gary L. French (Age 64)Treasurer John W. Clark (Age 46)Assistant Treasurer Matthew W. Flaherty (Age 42)Assistant Treasurer Chad C. Hallett (Age 47)Assistant Treasurer of Street tracks series trust Mary Moran Zeven (Age 52)Secretary Scott M. Zoltowski (Age 44)Assistant Secretary Dave KellyIndependent TrusteeMore ExecutivesSimilar ETFsInvesco S&P SmallCap Health Care ETFNASDAQ:PSCHDirexion Daily Healthcare Bull 3x SharesNYSEARCA:CURESimplify Health Care ETFNYSEARCA:PINKSPDR S&P Health Care Equipment ETFNYSEARCA:XHEInvesco Dorsey Wright Healthcare Momentum ETFNASDAQ:PTHInstitutional OwnershipFirst Citizens Bank & Trust Co.Bought 1,709 shares on 7/20/2024Ownership: 1.357%AlphaMark Advisors LLCBought 5,877 shares on 7/17/2024Ownership: 0.121%Envestnet Portfolio Solutions Inc.Bought 1,510 shares on 7/16/2024Ownership: 1.207%U.S. Capital Wealth Advisors LLCBought 5,531 shares on 7/11/2024Ownership: 0.372%CX InstitutionalBought 5,240 shares on 7/11/2024Ownership: 0.200%View All Institutional Transactions XPH ETF - Frequently Asked Questions How have XPH shares performed this year? SPDR S&P Pharmaceuticals ETF's stock was trading at $41.62 at the beginning of the year. Since then, XPH shares have increased by 4.0% and is now trading at $43.27. View the best growth stocks for 2024 here. Who are SPDR S&P Pharmaceuticals ETF's major shareholders? Top institutional investors of SPDR S&P Pharmaceuticals ETF include First Citizens Bank & Trust Co. (1.36%), Envestnet Portfolio Solutions Inc. (1.21%), U.S. Capital Wealth Advisors LLC (0.37%) and CX Institutional (0.20%). How do I buy shares of SPDR S&P Pharmaceuticals ETF? Shares of XPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of SPDR S&P Pharmaceuticals ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that SPDR S&P Pharmaceuticals ETF investors own include Pfizer (PFE), Bank of America (BAC), Micron Technology (MU), Broadcom (AVGO), Chevron (CVX), DocuSign (DOCU) and SPDR Gold Shares (GLD). This page (NYSEARCA:XPH) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share SPDR S&P Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
